Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCI

Title: Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCI
Authors: Choi, KH; Song, YB; Lee, JM; Park, TK; Yang, JH; Hahn, JY; Choi, JH; Choi, SH; Kim, HS; Chun, WJ; Hur, SH; Han, SH; Rha, SW; Chae, IH; Jeong, JO; Heo, JH; Yoon, J; Lim, DS; Park, JS; Hong, MK; Doh, JH; Cha, KS; Kim, DI; Lee, SY; Chang, K; Hwang, BH; Choi, SY; Jeong, MH; Hong, SJ; Nam, CW; Koo, BK; Gwon, HC
Contributors: 101511; Choi, SY
Publication Year: 2021
Subject Terms: bifurcation; drug-eluting stents; outcomes; percutaneous coronary intervention
Description: Background: There is a paucity of data regarding the long-term clinical outcomes of first- versus second-generation drug-eluting stent (DES), especially when used to treat complex lesions such as bifurcation lesions. Objectives: The current study compares the efficacy and safety of first- versus second-generation DES at the 5-year follow-up in patients who underwent bifurcation percutaneous coronary intervention (PCI). Methods: A total of 5,498 patients with a bifurcation lesion who underwent PCI were pooled at a single patient level from COBIS (Coronary Bifurcation Stenting) registries II and III. Five-year target lesion failure (TLF) (the composite of cardiac death, myocardial infarction [MI], and target lesion revascularization [TLR]) and cardiac death or MI were compared between the use of first-generation DES (n = 2,436) and second-generation DES (n = 3,062) during PCI. Propensity score matching was performed to reduce selection bias. Results: After a 1:1 propensity score matching procedure was conducted, the cohort consisted of 1,702 matched pairs. Patients treated with second-generation DES had a significantly lower risk of TLF at 5 years than those treated with first-generation DES in both overall and propensity-matched populations (matched hazard ratio [HRmatched]: 0.576; 95% confidence interval [CI]: 0.456 to 0.727; p
Document Type: article in journal/newspaper
Language: English
ISSN: 36338362
Relation: J027723747; http://repository.ajou.ac.kr/handle/201003/23411; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627880/
DOI: 10.1016/j.jacasi.2021.04.006
Availability: http://repository.ajou.ac.kr/handle/201003/23411; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627880/; https://doi.org/10.1016/j.jacasi.2021.04.006
Accession Number: edsbas.B4AC6811
Database: BASE